renilla prl sv40p plasmid (Addgene inc)
Addgene inc is a verified supplier 
93
Structured Review
Addgene inc
renilla prl sv40p plasmid
Renilla Prl Sv40p Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 119 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/renilla+prl+sv40p+plasmid/pRL-SV40P+(Plasmid+%2327163)/pm41935049-280-38-44
Average 93 stars, based on 119 article reviews
Renilla Prl Sv40p Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 119 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/renilla+prl+sv40p+plasmid/pRL-SV40P+(Plasmid+%2327163)/pm41935049-280-38-44
Average 93 stars, based on 119 article reviews
renilla prl sv40p plasmid - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Activity Assay:Article Title: Inhibition of circulating glycocholic acid-regulated signaling potentiates immune checkpoint therapy in colorectal cancer. Article Snippet: .. For measurement of FXR activity, cells were seeded into 24-well plates at ~1.5x104 cells per well and transfected with the FXR luciferase reporter plasmid FXRE-Luc (200 ng; cat. no. 11764ES03; Shanghai Yeasen Biotechnology Co., Ltd.) and 20 ng Transfection:Article Title: Inhibition of circulating glycocholic acid-regulated signaling potentiates immune checkpoint therapy in colorectal cancer. Article Snippet: .. For measurement of FXR activity, cells were seeded into 24-well plates at ~1.5x104 cells per well and transfected with the FXR luciferase reporter plasmid FXRE-Luc (200 ng; cat. no. 11764ES03; Shanghai Yeasen Biotechnology Co., Ltd.) and 20 ng Luciferase:Article Title: Inhibition of circulating glycocholic acid-regulated signaling potentiates immune checkpoint therapy in colorectal cancer. Article Snippet: .. For measurement of FXR activity, cells were seeded into 24-well plates at ~1.5x104 cells per well and transfected with the FXR luciferase reporter plasmid FXRE-Luc (200 ng; cat. no. 11764ES03; Shanghai Yeasen Biotechnology Co., Ltd.) and 20 ng Plasmid Preparation:Article Title: Inhibition of circulating glycocholic acid-regulated signaling potentiates immune checkpoint therapy in colorectal cancer. Article Snippet: .. For measurement of FXR activity, cells were seeded into 24-well plates at ~1.5x104 cells per well and transfected with the FXR luciferase reporter plasmid FXRE-Luc (200 ng; cat. no. 11764ES03; Shanghai Yeasen Biotechnology Co., Ltd.) and 20 ng Article Title: Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance Article Snippet: Tumor cells were seeded into 96-well plates with at 50%-70% confluency and then transfected into five copies using Lipofectamine 3000 (Life Technologies, L3000–075) according to the manufacturer’s manual. .. In detail, 150 ng of each experimental plasmid (pGL4.10 empty vector, pENTER empty vector, pGL4.10-USP14, pENTER STAT3 or pGL4.10-USP14-STAT3 mutation vector [Shanghai OBiO Technology]) and 7.5 ng of the Article Title: Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Article Snippet: Dual luciferase Reporter assay Tumor cells were seeded into 96-well plates with at 50%-70% confluency and then transfected into five copies using Lipofectamine 3000 (Life Technologies, L3000–075) according to the manufacturer’s manual. .. In detail, 150 ng of each experimental plasmid (pGL4.10 empty vector, pENTER empty vector, pGL4.10-USP14, pENTER STAT3 or pGL4.10USP14-STAT3 mutation vector [Shanghai OBiO Technology]) and 7.5 ng of the Mutagenesis:Article Title: Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance Article Snippet: Tumor cells were seeded into 96-well plates with at 50%-70% confluency and then transfected into five copies using Lipofectamine 3000 (Life Technologies, L3000–075) according to the manufacturer’s manual. .. In detail, 150 ng of each experimental plasmid (pGL4.10 empty vector, pENTER empty vector, pGL4.10-USP14, pENTER STAT3 or pGL4.10-USP14-STAT3 mutation vector [Shanghai OBiO Technology]) and 7.5 ng of the Article Title: Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Article Snippet: Dual luciferase Reporter assay Tumor cells were seeded into 96-well plates with at 50%-70% confluency and then transfected into five copies using Lipofectamine 3000 (Life Technologies, L3000–075) according to the manufacturer’s manual. .. In detail, 150 ng of each experimental plasmid (pGL4.10 empty vector, pENTER empty vector, pGL4.10-USP14, pENTER STAT3 or pGL4.10USP14-STAT3 mutation vector [Shanghai OBiO Technology]) and 7.5 ng of the |
